John R Keefe1, Barbara L Milrod2, Robert Gallop3, Jacques P Barber4, Dianne L Chambless1. 1. Department of Psychology, University of Pennsylvania, Philadelphia, PA, USA. 2. Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA. 3. Department of Mathematics, West Chester University, West Chester, PA, USA. 4. Derner Institute of Advanced Psychological Studies, Adelphi University, Garden City, NY, USA.
Abstract
BACKGROUND: No studies of psychotherapies for panic disorder (PD) have examined effects on comorbid personality disorders (PersD), yet half such patients have a PersD. METHODS: In a randomized trial for PD with and without agoraphobia comparing Cognitive-Behavioral Therapy (CBT) and Panic-Focused Psychodynamic Psychotherapy (PFPP), PersD was assessed pre-to-post treatment with the Structured Clinical Interview for the Diagnosis of Axis-II Disorders (SCID-II). For patients completing therapy (n = 118, 54 with PersD), covariance between panic and SCID-II criteria improvements was analyzed. SCID-II diagnostic remission and recovery were evaluated. Comparative efficacy of PFPP versus CBT for improving PersD was analyzed both for the average patient, and as a function of PersD severity. RESULTS: 37 and 17% of PersD patients experienced diagnostic PersD remission and recovery, respectively. Larger reductions in PersD were related to more panic improvement, with a modest effect size (r = 0.28). Although there was no difference between treatments in their ability to improve PersD for the average patient (d = 0.01), patients meeting more PersD criteria did better in PFPP compared to CBT (P = .007), with PFPP being significantly superior at 11 criteria and above (d = 0.66; 3 more criteria lost). CONCLUSIONS: PersD presenting in the context of primary PD rarely resolves during psychotherapies focused on PD, and change in PersD only moderately tracks panic improvements, indicating non-overlap of the constructs. Patients receiving panic-focused psychotherapies may require additional treatment for their PersD. PFPP may be superior at improving severe PersD, but replication of this finding is required.
RCT Entities:
BACKGROUND: No studies of psychotherapies for panic disorder (PD) have examined effects on comorbid personality disorders (PersD), yet half such patients have a PersD. METHODS: In a randomized trial for PD with and without agoraphobia comparing Cognitive-Behavioral Therapy (CBT) and Panic-Focused Psychodynamic Psychotherapy (PFPP), PersD was assessed pre-to-post treatment with the Structured Clinical Interview for the Diagnosis of Axis-II Disorders (SCID-II). For patients completing therapy (n = 118, 54 with PersD), covariance between panic and SCID-II criteria improvements was analyzed. SCID-II diagnostic remission and recovery were evaluated. Comparative efficacy of PFPP versus CBT for improving PersD was analyzed both for the average patient, and as a function of PersD severity. RESULTS: 37 and 17% of PersD patients experienced diagnostic PersD remission and recovery, respectively. Larger reductions in PersD were related to more panic improvement, with a modest effect size (r = 0.28). Although there was no difference between treatments in their ability to improve PersD for the average patient (d = 0.01), patients meeting more PersD criteria did better in PFPP compared to CBT (P = .007), with PFPP being significantly superior at 11 criteria and above (d = 0.66; 3 more criteria lost). CONCLUSIONS: PersD presenting in the context of primary PD rarely resolves during psychotherapies focused on PD, and change in PersD only moderately tracks panic improvements, indicating non-overlap of the constructs. Patients receiving panic-focused psychotherapies may require additional treatment for their PersD. PFPP may be superior at improving severe PersD, but replication of this finding is required.
Authors: Barbara Milrod; John C Markowitz; Andrew J Gerber; Jill Cyranowski; Margaret Altemus; Theodore Shapiro; Myron Hofer; Charles Glatt Journal: Am J Psychiatry Date: 2014-01 Impact factor: 18.112
Authors: S G Hofmann; M K Shear; D H Barlow; J M Gorman; D Hershberger; M Patterson; S W Woods Journal: Depress Anxiety Date: 1998 Impact factor: 6.505
Authors: Dianne L Chambless; Brian A Sharpless; Dianeth Rodriguez; Kevin S McCarthy; Barbara L Milrod; Shabad-Ratan Khalsa; Jacques P Barber Journal: Behav Ther Date: 2011-05-24
Authors: E B Ansell; A Pinto; M O Edelen; J C Markowitz; C A Sanislow; S Yen; M Zanarini; A E Skodol; M T Shea; L C Morey; J G Gunderson; T H McGlashan; C M Grilo Journal: Psychol Med Date: 2010-09-14 Impact factor: 7.723
Authors: M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp Journal: Am J Psychiatry Date: 1997-11 Impact factor: 18.112
Authors: Barbara Milrod; Andrew C Leon; Fredric Busch; Marie Rudden; Michael Schwalberg; John Clarkin; Andrew Aronson; Meriamne Singer; Wendy Turchin; E Toby Klass; Elizabeth Graf; Jed J Teres; M Katherine Shear Journal: Am J Psychiatry Date: 2007-02 Impact factor: 18.112
Authors: John R Keefe; Zeeshan M Huque; Robert J DeRubeis; Jacques P Barber; Barbara L Milrod; Dianne L Chambless Journal: Psychotherapy (Chic) Date: 2019-03-14
Authors: Nili Solomonov; Katie Aafjes van-Doorn; Lauren M Lipner; Bernard S Gorman; Barbara Milrod; Marie G Rudden; Dianne L Chambless; Jacques P Barber Journal: J Contemp Psychother Date: 2019-06-20
Authors: Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen Journal: Cochrane Database Syst Rev Date: 2020-05-04